These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26084216)

  • 21. Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed.
    Pakdeechote P; Dunn WR; Ralevic V
    Br J Pharmacol; 2007 Nov; 152(5):725-33. PubMed ID: 17641668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
    Baranowska-Kuczko M; Kozłowska H; Kloza M; Karpińska O; Toczek M; Harasim E; Kasacka I; Malinowska B
    Life Sci; 2016 Apr; 151():288-299. PubMed ID: 26969765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats.
    Resstel LB; Lisboa SF; Aguiar DC; Corrêa FM; Guimarães FS
    Psychopharmacology (Berl); 2008 Jun; 198(3):405-11. PubMed ID: 18446325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Kokona D; Thermos K
    Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoids in acute gastric damage and pancreatitis.
    Dembiński A; Warzecha Z; Ceranowicz P; Dembiński M; Cieszkowski J; Pawlik WW; Konturek SJ; Tomaszewska R; Hładki W; Konturek PC
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 5():137-54. PubMed ID: 17218765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous cannabinoids induce fever through the activation of CB1 receptors.
    Fraga D; Zanoni CI; Rae GA; Parada CA; Souza GE
    Br J Pharmacol; 2009 Aug; 157(8):1494-501. PubMed ID: 19681872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.
    Niederhoffer N; Szabo B
    Br J Pharmacol; 1999 Jan; 126(2):457-66. PubMed ID: 10077239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CB
    Dos Anjos-Garcia T; Ullah F; Falconi-Sobrinho LL; Coimbra NC
    Neuropharmacology; 2017 Feb; 113(Pt A):156-166. PubMed ID: 27062913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.
    Bermúdez-Siva FJ; Serrano A; Diaz-Molina FJ; Sánchez Vera I; Juan-Pico P; Nadal A; Fuentes E; Rodríguez de Fonseca F
    Eur J Pharmacol; 2006 Feb; 531(1-3):282-4. PubMed ID: 16423347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning.
    Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VR1-mediated depressor effects during high-salt intake: role of anandamide.
    Wang Y; Kaminski NE; Wang DH
    Hypertension; 2005 Oct; 46(4):986-91. PubMed ID: 16144988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.
    Seillier A; Martinez AA; Giuffrida A
    Neuropsychopharmacology; 2013 Aug; 38(9):1816-24. PubMed ID: 23563893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of cannabinoids on immunoreactivity of regulatory peptides, produced in rat thyroid C cells; preliminary investigations.
    Sawicki B; Zbucki RL; Hryniewicz A; Kosiorek P; Bialuk I; Winnicka MM; Dadan J
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():143-5. PubMed ID: 15638402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
    Romero TR; Resende LC; Guzzo LS; Duarte ID
    Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.
    Wagner JA; Járai Z; Bátkai S; Kunos G
    Eur J Pharmacol; 2001 Jul; 423(2-3):203-10. PubMed ID: 11448486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid type-1 receptors in the paraventricular nucleus of the hypothalamus inhibit stimulated food intake.
    Soria-Gómez E; Massa F; Bellocchio L; Rueda-Orozco PE; Ciofi P; Cota D; Oliet SH; Prospéro-García O; Marsicano G
    Neuroscience; 2014 Mar; 263():46-53. PubMed ID: 24434770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats.
    Kozan R; Ayyildiz M; Agar E
    Epilepsia; 2009 Jul; 50(7):1760-7. PubMed ID: 19453709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoids cause central sympathoexcitation and bradycardia in rabbits.
    Niederhoffer N; Szabo B
    J Pharmacol Exp Ther; 2000 Aug; 294(2):707-13. PubMed ID: 10900251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection: immunocytochemistry, autoradiography and behavioral studies.
    Castelli MP; Piras AP; Melis T; Succu S; Sanna F; Melis MR; Collu S; Ennas MG; Diaz G; Mackie K; Argiolas A
    Neuroscience; 2007 Jun; 147(1):197-206. PubMed ID: 17507169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
    Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
    Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.